Perdipine



Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 13.6%
Constipation 10.2%
Convulsion Prophylaxis 10.2%
Drug Use For Unknown Indication 10.2%
Infection 10.2%
Cerebral Infarction 6.8%
Prophylaxis 5.1%
Fluid Replacement 3.4%
Gastric Ulcer 3.4%
Gastritis 3.4%
Hyperglycaemia 3.4%
Infection Prophylaxis 3.4%
Neurogenic Bladder 3.4%
Nutritional Support 3.4%
Pyrexia 3.4%
Vitamin Supplementation 3.4%
Hypercholesterolaemia 1.7%
Blood Pressure Management 0.8%
Myasthenia Gravis 0.8%
Stevens-johnson Syndrome 28.6%
Purpura 21.4%
Inflammatory Bowel Disease 14.3%
Liver Disorder 14.3%
Ileus Paralytic 7.1%
Renal Impairment 7.1%
White Blood Cell Count Increased 7.1%
Secondary
Hypertension 26.0%
Sedation 11.0%
Vitamin Supplementation 9.1%
Pneumonia 7.3%
Anaesthesia Procedure 5.5%
Diuretic Therapy 5.5%
Mineral Supplementation 5.5%
Wound Complication 3.7%
Cerebral Infarction 3.2%
Product Used For Unknown Indication 3.2%
Airway Burns 2.7%
Constipation 2.7%
Infection 2.7%
Muscle Relaxant Therapy 2.7%
Renal Hypertension 2.7%
Convulsion Prophylaxis 1.8%
Thermal Burn 1.8%
Asthma 0.9%
Cerebral Haemorrhage 0.9%
Drug Use For Unknown Indication 0.9%
Laryngeal Oedema 42.1%
Toxic Epidermal Necrolysis 15.8%
Liver Disorder 7.9%
Malaise 7.9%
Atrioventricular Block Complete 5.3%
Interstitial Lung Disease 5.3%
Papuloerythroderma Of Ofuji 5.3%
Stevens-johnson Syndrome 5.3%
Aortic Dissection 2.6%
Phlebitis 2.6%
Concomitant
Hypertension 15.1%
Sedation 9.1%
Fluid Replacement 8.9%
Prophylaxis 8.4%
Infection 7.7%
Ureteral Stent Insertion 6.2%
Ureteral Stent Removal 6.2%
Infection Prophylaxis 4.6%
Diuretic Therapy 3.9%
Drug Use For Unknown Indication 3.9%
Insomnia 3.6%
Product Used For Unknown Indication 3.3%
Pyrexia 3.3%
Prophylaxis Against Graft Versus Host Disease 3.1%
Anticoagulant Therapy 2.6%
Electrolyte Substitution Therapy 2.3%
Constipation 2.2%
Acute Myocardial Infarction 2.0%
Mineral Supplementation 2.0%
Hypokalaemia 1.7%
Respiratory Failure 19.5%
Rhabdomyolysis 8.6%
Staphylococcal Infection 7.0%
Pneumonia Aspiration 5.5%
Loss Of Consciousness 4.7%
Viral Infection 4.7%
White Blood Cell Count Increased 4.7%
Delayed Recovery From Anaesthesia 3.9%
Interstitial Lung Disease 3.9%
Purpura 3.9%
Septic Shock 3.9%
Shock 3.9%
Visual Field Defect 3.9%
Cardiac Failure 3.1%
Cerebral Haemorrhage 3.1%
Platelet Count Decreased 3.1%
Sepsis 3.1%
Thrombotic Microangiopathy 3.1%
Toxic Epidermal Necrolysis 3.1%
Vasogenic Cerebral Oedema 3.1%
Interacting
Hypertension 100.0%
Urine Output Decreased 100.0%